www.fdanews.com/articles/75946-amdl-announces-second-closing-of-private-offering
AMDL ANNOUNCES SECOND CLOSING OF PRIVATE OFFERING
August 31, 2005
AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has conducted the second closing of a combined Regulation D/Regulation S private offering of shares and warrants. The offering generated total gross proceeds of $1,007,000, exclusive of placement agent fees of $130,910.